Is the concept of 'cardiometabolic risk' more useful than 'metabolic syndrome'? [1]

Diabetic Medicine

Volumn 24, Issue 5, 2007, Pages 571-

  Koshiyama, H ^a,b   Taniguchi, A ^b,c   Inagaki, N ^b   Seino, Y ^c  

^a Kitano Hospital   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KANSAI DENRYOKU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; HUMAN; INSULIN DEFICIENCY; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; RISK FACTORS;

EID: 34247563923     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02174.x     Document Type: Letter

References (12)

1. Kahn R, Buse J, Ferrannini E, Stern M, for the American Diabetes Association and the European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal (ADA statement). Diabetes Care 2005 28 : 2289 2304.
2. Grundy S, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. for the American Heart Association and the National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome (scientific statement). Circulation 2005 112 : 2735 2752.
3. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung and Blood Institute. Arterioscler Thromb Vasc Biol 2005 25 : 2243 2244.
4. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Diabetes Care 2006 29 : 1697 1699.
5. Koshiyama H, Honjo S, Hamamoto Y, Ikeda H, Wada Y. Drugs share anti-diabetic and anti-athersclerotic actions though 'the common soil.' Med Hypotheses 2006 66 : 473 475.
6. Lawlor DA, Lean M, Sattar N. Obesity and vascular disease. Br Med J 2006 333 : 1060 1063.
7. Mandavilli A, Cyranoski D. ' Asia's big problem'. Nat Med 2004 10 : 325.
8. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I et al. Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 1992 41 : 1540 1546.
9. Haffner SM, D'Agostino R Jr, Mykkanen L, Tracy R, Howard B, Rewers M et al. Insulin sensitivity in subjects with type 2 diabetes: relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1999 22 : 562 568.
10. Taniguchi A, Nakai Y, Fukushima M, Nagata I, Kawamura H, Imura H et al. Glucose effectiveness in two subjects within impaired glucose tolerance. A minimal model analysis. Diabetes 1994 43 : 1211 1217.
11. Mitsui R, Fukushima M, Nishi Y, Ueda N, Suzuki H, Taniguchi A et al. Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men. Metabolism 2006 55 : 53 58.
12. Bergman RN. Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 1989 38 : 1512 1527.